UNSPSC 51111776: Podofilox

This classification denotes a colchicine-site binding agent with the molecular formula C22H22O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L36H50F353, chemically known as furo(3,4:6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)- but more generally known as podofilox, which bears US NIH Compound Identifier 4865. European Medicines Agency schedules Podofilox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14925MIG.

World Health Organization schedules podofilox in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, PODOFILOX remains US FDA's Preferred Term for this commodity. Podofilox bears US NLM identifiers UMLS ID C0032334 and NCI Concept Code C29368. SMILES: O1CC2C(C(C3C(C2O)CC2OCOC2C3)C2CC(OC)C(OC)C(OC)C2)C1=O.

UNSPSC 51111776 Podofilox (Commodity) represents a pharmaceutical active ingredient and finished-dose product that state and local health agencies, emergency services, and cooperative purchasing alliances are procuring through competitive bidding and multi-vendor RFPs, though recent activity shows only tangential relevance to the code's nominal scope. The actual procurement activity under this code classification centers on naloxone and drug deactivation systems (emergency overdose response), generic multi-source pharmaceuticals and OTC products distributed through state cooperative purchasing vehicles, and medical/first-aid supplies for fire departments and rescue operations. State and local buying bodies soliciting under or adjacent to this code include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal purchasing departments (City of Tampa), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state, local, and participating regional governments). The mix reflects both direct government procurement and cooperative-purchasing mechanisms that aggregate demand across state and local members.

Geographic activity centers on Florida, Texas, and Minnesota, with cooperative purchasing extending to Oregon and other member states. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to Sanford, Florida, under a two-year term with one-year renewal option; the City of Tampa's invitation to bid 26P00145 (posted March 2026, due March 13, 2026) for 169 line items of medical and first-aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5% bid discount; and the Minnesota Department of Administration's MMCAP RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be distributed through authorized wholesalers effective July 1, 2026. The Texas HHS RFI HHS0017013 (April 2026) signals exploratory procurement around direct-to-manufacturer prescription programs but represents preliminary market research rather than a formal solicitation. Note that the Seminole County and Tampa opportunities, while tagged under this code, address overdose-response and emergency-medical supplies rather than podofilox specifically, indicating potential classification drift in the source tagging.